Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor
Jia Yu, Fen Xiong, Yingruo Xu, Hanyan Xu, Xi Zhang, Hongchang Gao, Yuping Li
Topics & Concepts
LipidomicsInternal medicineBiomarkerAdverse effectMedicineOncologyCohortLung cancerReceiver operating characteristicArea under the curveProspective cohort studyCancerImmune systemGastroenterologyImmunologyBioinformaticsBiologyBiochemistryCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmune cells in cancer